<DOC>
	<DOCNO>NCT00671619</DOCNO>
	<brief_summary>Objectives : To evaluate safety , tolerability pharmacokinetics ESBA105 administer topically eye 28 day healthy volunteer . To determine systemic exposure ESBA105 upon single repeated-dose topical application eye healthy volunteer .</brief_summary>
	<brief_title>Study ESBA105 Eye Drops Healthy Subjects</brief_title>
	<detailed_description>ESBA105 anti TNF single chain antibody fragment</detailed_description>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Tetrahydrozoline</mesh_term>
	<criteria>Male female Caucasian subject . Written inform consent prior study procedure include screen test eligibility . Subjects good health determine past medical history , physical examination , vital sign , electrocardiogram , laboratory test screen . Normal sit blood pressure pulse rate , i.e . : BP : 100160 mm Hg systolic , 5090 mm Hg diastolic pulse rate : 45100 bpm . Blood pressure pulse measure 3 minute rest sit position . Bilateral correct visual acuity least 0.9 No need regular concomitant medication . Ability communicate well investigator comply requirement entire study . Use qualified contraception Any evidence infectious disease evidence medical history , clinical examination , positive serology result indicate presence hepatitis B and/ C HIV infection positive result QuantiFERON TB Gold test base latent tuberculosis test . History serious adverse reaction hypersensitivity drug . Presence history allergy include allergic conjunctivitis require acute chronic treatment ( seasonal allergic rhinitis associate conjunctivitis require treatment may tolerate ) . Abnormal physical finding clinical significance screen examination baseline would interfere objective study . Existence surgical medical condition might interfere evaluation general drug safety tolerability include clinically relevant ophthalmological disease , impair renal hepatic function , diabetes mellitus , cardiovascular abnormality , haematological abnormality , psychiatric disease , chronic symptom pronounce constipation diarrhoea condition associate total partial obstruction urinary tract . Shallow anterior chamber , close angle glaucoma contraindication eye dilation ophthalmological examination . History presence clinically relevant ( opinion Investigator ) ocular disease .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>August 2008</verification_date>
	<keyword>opthalmology</keyword>
	<keyword>antibody fragment</keyword>
	<keyword>TNF alpha</keyword>
</DOC>